Articles From: Lilly Announces Diabetes Research Partnership with University of Surrey to Limoneira to Present at the 17th Annual ICR XChange Conference


The five-year collaboration with the UK public research university will focus on health outcomes for people with type 2 diabetes INDIANAPOLIS , Dec.
Sign-up for Lilly Announces Diabetes Research Partnership with University of Surrey investment picks
INDIANAPOLIS , Dec.
Sign-up for Lilly Announces Dividend Increase investment picks
Lilly plans to increase its business development activities to support its external innovation strategy INDIANAPOLIS , Jan.
Sign-up for Lilly Announces Promotion of Darren J. Carroll to Senior Vice President of Corporate Business Development investment picks
INDIANAPOLIS , Jan.
Sign-up for Lilly Finalizes Novartis Animal Health Acquisition investment picks
2015/1/7
- The company describes refinements to its innovation-based strategy, including greater focus on core therapeutic areas and key geographies.
Sign-up for Lilly Provides Update on Strategy and Announces 2015 Financial Guidance investment picks
2014/10/23
INDIANAPOLIS , Oct.
Sign-up for Lilly Reports Third-Quarter 2014 Results investment picks
INDIANAPOLIS , Oct.
Sign-up for Lilly Responds to Decision in Case of Terrence Allen, et al. v. Takeda investment picks
New white paper documents Lilly's philanthropic effort to expand access to multidrug-resistant tuberculosis medicines INDIANAPOLIS , Oct.
Sign-up for Lilly Shares Insights from Decade-Long Technology Transfer Experience investment picks
INDIANAPOLIS , Oct.
Sign-up for Lilly to Participate in Credit Suisse 2014 Healthcare Conference investment picks
INDIANAPOLIS , Jan.
Sign-up for Lilly to Present at J.P. Morgan Healthcare Conference investment picks
Lilly Foundation matches donations from Lilly and Elanco employees, retirees to support children, families in the U.S. and Puerto Rico INDIANAPOLIS , Oct.
Sign-up for Lilly to Present Record-Breaking $12.7 Million Gift to United Way investment picks
2014/12/8
Eli Lilly and Company, Anthem, Inc. and HealthCore, Inc. announced today that they have formed a five-year, real-world evidence research collaboration intended to improve health outcomes for patients.
Sign-up for Lilly, Anthem, Inc. and HealthCore Create Research Collaboration to Improve Health Outcomes investment picks
Merck (NYSE:MRK), known as MSD outside the US and Canada, and Eli Lilly and Company (NYSE:LLY) announced today an oncology clinical trial collaboration to evaluate the safety, tolerability and efficacy of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Lilly compounds in multiple clinical trials: The agreement is between Lilly and Merck, through a subsidiary.
Sign-up for Lilly, Merck Enter Collaboration Agreement to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer investment picks
CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy INDIANAPOLIS , Nov.
Sign-up for Lilly's CYRAMZA® (ramucirumab) in Combination with Paclitaxel Granted FDA Approval for Advanced Gastric Cancer After Prior Chemotherapy investment picks
2014/11/10
Once-weekly treatment for adults with type 2 diabetes comes in a pen with a no-see, no-handle needle INDIANAPOLIS , Nov.
Sign-up for Lilly's Trulicity™ (dulaglutide) Now Available in U.S. Pharmacies investment picks
HUNTERSVILLE, N.C., Nov.
Sign-up for Lime Energy Q3 Results and Call Scheduled for November 12th investment picks
Lime Energy Co.
Sign-up for Lime Energy Raises $10 Million to Fund Growth investment picks
Limelight Networks, Inc. (“Limelight”) (Nasdaq:LLNW), a global leader in digital content delivery, today announced the Limelight Orchestrate™ (“Orchestrate”) Solution for Gaming .
Sign-up for Limelight Announces the Limelight Orchestrate™ Solution for Gaming investment picks
Limelight Networks, Inc. (“Limelight”) (Nasdaq:LLNW), a global leader in digital content delivery, today announced its participation at Streaming Media West .
Sign-up for Limelight Networks to Present at Streaming Media West investment picks
Limelight Networks, Inc. (Nasdaq:LLNW) will report financial results for the fourth quarter 2014 on Monday, February 2, 2015 at approximately 4:00 p.m. EST (2:00 p.m. MST). At approximately 4:30 p.m. EST (2:30 p.m. MST), management will host a quarterly conference call for investors.
Sign-up for Limelight Networks, Inc. to Issue Fourth Quarter 2014 Financial Results on Monday, February 2 at 4:00 p.m. EST investment picks
Limelight Networks, Inc. (Nasdaq:LLNW) ("Limelight"), a global leader in digital content delivery, today reported revenue of $39.0 million for the quarter ended September 30, 2014, compared to $42.7 million in the third quarter of 2013 and $41.3 million in the second quarter of 2014.
Sign-up for Limelight Networks(R) Reports Financial Results for the Third Quarter of 2014 investment picks
Limoneira Company (the “Company” or “Limoneira”) (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today reported financial results for the fourth quarter and fiscal year ended October 31, 2014.
Sign-up for Limoneira Company Announces Fourth Quarter and Fiscal Year 2014 Financial Results investment picks
On December 16, 2014, the Board of Directors of Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, declared a quarterly cash dividend of $0.045 per common share payable on January 15, 2015, to stockholders of record on December 29, 2014.
Sign-up for Limoneira Declares Quarterly Dividend investment picks
Limoneira Company (NASDAQ:LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California, announced today that Mark Palamountain has been promoted to the position of Senior Director, Agricultural Operations.
Sign-up for Limoneira Promotes Mark Palamountain to Senior Director, Agricultural Operations of Business Development and Business Integration investment picks
Limoneira Company (the “Company” or “Limoneira”) (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, announced today that it has rescheduled the Santa Paula city council hearing, previously scheduled for December 15, 2014, until February 2015.
Sign-up for Limoneira Reschedules Hearing to Provide Newly Elected City Council Members Additional Time to Review Updated Specific Plan and Development Agreement investment picks
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced it will release financial results for the fourth quarter and full year ended October 31, 2014, on Monday, January 12, 2015, after the market close.
Sign-up for Limoneira to Announce Fourth Quarter and Full Year Fiscal 2014 Financial Results on January 12, 2015 investment picks
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced that Harold Edwards, the Company's Chief Executive Officer, and Mark Palamountain, the Company’s Senior Director, Agricultural Operations, will be presenting at the 17 th Annual ICR XChange Conference, to be held January 12-14, 2015, at the JW Marriott Orlando Grande Lakes in Orlando, Florida.
Sign-up for Limoneira to Present at the 17th Annual ICR XChange Conference investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Lilly Announces Diabetes Research Partnership with University of Surrey to Limoneira to Present at the 17th Annual ICR XChange Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent